Abstract
Chronic obstructive pulmonary disease (COPD) affects over 10% of the adult population worldwide and is currently projected to become the third leading cause of death by year 2030 [1]. We believe, COPD should be viewed as a multisystem disorder with clearly identified extra-pulmonary manifestations including weight loss, myopathy, cardiovascular diseases, diabetes, malignancies, bone mineral disease and psychological disorders. Most of these comorbidities are also important not only to understand the burden of this progressive disease, but also to devise effective therapeutic strategies [2]. This article reviews the current understanding of the systemic manifestations of COPD, which includes everything except airflow obstruction, emphysema and chronic bronchitis. For colleagues interested in reviewing the main component of COPD therapy, we urge to review an excellent article published in American Journal of Respiratory Critical Care Medicine volume 187, page 337- 365, Feb 15, 2013.
Keywords: Airflow obstruction, chronic bronchitis, COPD, pneumonia, pulmonary disease, pulmonary venous thrombo-embolism.
Current Respiratory Medicine Reviews
Title:COPD Evaluation: Beyond the Airway Obstruction, a Follow Up
Volume: 9 Issue: 2
Author(s): Asif Najmuddin, Naga Sirikonda and Harakh V. Dedhia
Affiliation:
Keywords: Airflow obstruction, chronic bronchitis, COPD, pneumonia, pulmonary disease, pulmonary venous thrombo-embolism.
Abstract: Chronic obstructive pulmonary disease (COPD) affects over 10% of the adult population worldwide and is currently projected to become the third leading cause of death by year 2030 [1]. We believe, COPD should be viewed as a multisystem disorder with clearly identified extra-pulmonary manifestations including weight loss, myopathy, cardiovascular diseases, diabetes, malignancies, bone mineral disease and psychological disorders. Most of these comorbidities are also important not only to understand the burden of this progressive disease, but also to devise effective therapeutic strategies [2]. This article reviews the current understanding of the systemic manifestations of COPD, which includes everything except airflow obstruction, emphysema and chronic bronchitis. For colleagues interested in reviewing the main component of COPD therapy, we urge to review an excellent article published in American Journal of Respiratory Critical Care Medicine volume 187, page 337- 365, Feb 15, 2013.
Export Options
About this article
Cite this article as:
Najmuddin Asif, Sirikonda Naga and Dedhia V. Harakh, COPD Evaluation: Beyond the Airway Obstruction, a Follow Up, Current Respiratory Medicine Reviews 2013; 9 (2) . https://dx.doi.org/10.2174/1573398X113099990002
DOI https://dx.doi.org/10.2174/1573398X113099990002 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Therapeutic Implications of Tocilizumab, A Humanized Anti-Interleukin-6 Receptor Antibody, for Various Immune-Mediated Diseases: An Update Review
Current Rheumatology Reviews Meet Our Editorial Board Member
Current Medical Imaging PEGylation: An Overview and Recent Advances Reported in the Patent Literature
Recent Patents on Chemical Engineering Biological Signals Sensing with Wearable Technologies and an ECG Athlete Design
Recent Patents on Biomedical Engineering (Discontinued) Hypothyroidism and Cardiovascular Disease: Factors, Mechanism and Future Perspectives
Current Medicinal Chemistry Endothelial Progenitor Cells and In-stent Restenosis
Current Stem Cell Research & Therapy High Serum Alkaline Phosphatase Levels in Relation to Multi-Cerebral Microbleeds in Acute Ischemic Stroke Patients with Atrial Fibrillation and/or Rheumatic Heart Disease
Current Neurovascular Research Noninvasive Vascular Strain Imaging: from Methods to Application
Current Medical Imaging Cardiovascular Complications in Patients with Klinefelter’s Syndrome
Current Pharmaceutical Design Hydrogen Peroxide Produced by Mitochondrial Monoamine Oxidase Catalysis: Biological Implications
Current Pharmaceutical Design Are Carbonic Anhydrase Inhibitors Suitable for Obtaining Antiobesity Drugs ?
Current Pharmaceutical Design Cardioactive Agents from Plants
Mini-Reviews in Medicinal Chemistry Imaging Patterns of Cardiovascular Involvement in Mixed Connective Tissue Disease Evaluated by Cardiovascular Magnetic Resonance
Inflammation & Allergy - Drug Targets (Discontinued) Blockade of the Renin-Angiotensin-Aldosterone System: Effects on Hypertensive Target Organ Damage
Cardiovascular & Hematological Agents in Medicinal Chemistry Development of Immunopharmacotherapy Against Drugs of Abuse
Current Drug Discovery Technologies Early, Intensive and Long-term Statin Therapy in Acute Coronary Syndrome: Focus on Anti-inflammatory Mechanisms
Vascular Disease Prevention (Discontinued) Genistein as a Potential Anticancer Agent Against Head and Neck Squamous Cell Carcinoma
Current Topics in Medicinal Chemistry Surgical Ventricular Restoration to Reverse Left Ventricular Remodeling
Current Cardiology Reviews Inhibitors of HMG-CoA Reductase: Current and Future Prospects
Mini-Reviews in Medicinal Chemistry Editorial (Novel Therapies and Botanical and Mechanical Approaches for Management of Cardiovascular Disease)
Recent Patents on Cardiovascular Drug Discovery